What is Ifa lose 2 mg ?
Ifa lose 2 mg is a tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. Ifa lose 2 mg is only approved in the United States for the treatment of Duchenne muscular dystrophy, and is not marketed or available in the United States for use in the treatment of obesity.Ifa lose 2 mg stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite.Ifa lose 2 mg is used as a short-term supplement to diet and exercise in the treatment of obesity.
Ifa lose 2 mg DOSAGE
Adult: Initially, 0.5-1 mg/day in the morning. May increase to 1.5-2 mg/day after 1 wk, depending on patient’s response. Max dose: 3 mg/day in divided doses. Treatment duration: 4-6 wk. Max: 12 wk.
Child: >12 yr: Initially, 0.5-1 mg/day in the morning. May increase to 1.5-2 mg/day after 1 wk, depending on patient’s response. Max dose: 3 mg/day in divided doses. Treatment duration: 4-6 wk. Max: 12 wk.
As a short-term (i.e. a few weeks) adjunct to continued dietary treatment in the medical
management of obesity, in patients who have not responded to an appropriate weight
reducing diet alone. Ifa lose 2 mg is recommended only for obese patients
with an initial body mass index of 30 kg/m
or higher, or 27 kg/m
or higher in the
presence of other risk factors (e.g. controlled hypertension, diabetes, hyperlipidemia).
BMI is calculated by taking the patient’s weight, in kg, divided by the patient’s height, in
how it is use :
When prescribing anorectic agents, it should be borne in mind that the role of these
drugs in the management of obesity is limited. Furthermore, the rate of weight loss
tends to decrease within a few weeks and a plateau is reached.
Treatment with Ifa lose 2 mg should only be given as part of a long-term integrated
therapeutic approach for weight reduction and weight maintenance under the care of a
physician with experience in the treatment of obesity. An appropriate approach to
obesity management should include dietary and behavioural modification as well as
increased physical activity. This integrated approach is essential for a lasting change in
eating habits and behaviour which is fundamental to the long-term maintenance of the
reduced weight level once it is stopped.